Bolt Biotherapeutics, Inc. is a startup based in the United States, most recent round Pre-ipo, 1 tracked investor.
Bolt Biotherapeutics, Inc. is a company founded in 2015 headquartered in the United States. Its most recent tracked round is Pre-ipo. Brouky records 1 investor associated with the company.
Bolt Biotherapeutics, Inc. is a clinical-stage biotechnology company developing a new class of immuno-oncology agents that combine antibody targeting with activation of innate and adaptive immune responses to treat cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.